ACTIVELLA®—Prescription hormone therapy with an estrogen just like your own. Now you can replace what your body is missing with what you want in a hormone therapy.
Postmenopausal bleeding profile
In a 12-month, prospective, double-blind, parallel-group, multicenter study of 583 postmenopausal women, 290 were randomized to receive ACTIVELLA® 1.0 mg/0.5 mg.
*Cumulative amenorrhea rate represents the percentage of women who were amenorrheic in a given cycle and remained so throughout the trial according to a retrospective analysis. If data were missing, the bleeding value from the last reported day was carried forward (LOCF).
- 1. ACTIVELLA® [package insert]. Princeton, NJ: Novo Nordisk Inc; 2007.
- 5. Ettinger B, Pressman A, Silver P. Effect of age on reasons for initiation and discontinuation of hormone replacement therapy. Menopause. 1999;6:282-289.
- 6. Johnson JV, Davidson M, Archer D, Bachmann G. Postmenopausal uterine bleeding profiles with two forms of continuous combined hormone replacement therapy. Menopause. 2002;9:16-22.
